Latest Market News

Algorae Pharmaceuticals has locked in a $3 million revolving debt facility with ScotPac, providing flexible, non-dilutive funding to accelerate its commercial operations across Australia and New Zealand.

Noxopharm has successfully completed the final multiple-dose cohort of its HERACLES trial for SOF-SKN™, reporting no significant safety concerns and paving the way for Phase II-enabling studies.

Energy Fuels Inc. has announced a proposed acquisition of Australian Strategic Materials (ASM) valued at approximately A$447 million, aiming to establish a leading Western rare earths and critical minerals producer with a fully integrated supply chain.

Energy Fuels Inc. has announced a binding agreement to acquire Australian Strategic Materials Ltd (ASM) in a deal valuing ASM at approximately A$447 million, offering shareholders a 121% premium. The acquisition aims to establish a vertically integrated Western rare earths supply chain, aligning with critical minerals strategies between the US and Australia.

Barton Gold Holdings reports final Phase 1 drilling results from its Tunkillia Gold Project, revealing shallow, high-grade gold intersections that underpin a $1.3 billion operating profit forecast. The company is set to commence Phase 2 drilling and advance towards a Mining Lease application in 2026.

Tivan Limited has made significant strides in its critical minerals portfolio, securing a $51.3 million strategic investment and progressing key feasibility studies across multiple projects.

BCAL Diagnostics has launched its Avantect pancreatic and ovarian cancer tests in Australia, alongside expanding clinical data and establishing a national registry for its BREASTESTplus breast cancer test.

AdAlta Limited has aligned its AdCella manufacturing strategy with new US FDA guidelines, made a significant milestone payment to Shanghai Cell Therapy Group, and secured an additional R&D tax rebate, marking key progress in its cellular immunotherapy pipeline.

Vulcan Energy has reported strong production test results from its LSC-1b sidetrack well, reinforcing the viability of its Phase One Lionheart lithium project in Germany. The well’s performance supports the project’s ambitious lithium and renewable energy production targets.

Aurelia Metals reports a strong December quarter with production ramp-ups ahead of schedule at Federation Mine and robust progress across its Peak and Great Cobar projects, underpinning solid cash flow and a healthy balance sheet.

Anteris Technologies has launched a $200 million public offering alongside a $90 million strategic investment from Medtronic, aiming to accelerate its DurAVR heart valve clinical trials and manufacturing expansion.

Lynas Rare Earths reported a 43% year-on-year revenue increase to A$201.9 million in Q2 FY26 despite a 30% drop in key NdPr production due to power disruptions and maintenance. The company also announced CEO Amanda Lacaze’s planned retirement at year-end.